So you'd rather them say nothing while the share p
Post# of 148095
I mean, I get it. Yes, I'd prefer a PR that they've launched the trial or gotten approval to launch. And boy do I wish we were closer to launching this thing. But in lieu of that, this is a very nice step in the direction of better communication with investors and the market.
Also, in reading the PR it's pretty clear this is a complicated AF kind of trial to run, and I'd prefer they get it right so I don't mind the back and forth here as much as I minded the surprise protocols and HIV shit the FDA made us go through.